Literature DB >> 10053012

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

M Gibbs1, J L Stanford, R A McIndoe, G P Jarvik, S Kolb, E L Goode, L Chakrabarti, E F Schuster, V A Buckley, E L Miller, S Brandzel, S Li, L Hood, E A Ostrander.   

Abstract

Combining data from a genomic screen in 70 families with a high risk for prostate cancer (PC) with data from candidate-region mapping in these families and an additional 71 families, we have localized a potential hereditary PC-susceptibility locus to chromosome 1p36. Because an excess of cases of primary brain cancer (BC) have been observed in some studies of families with a high risk for PC, and because loss of heterozygosity at 1p36 is frequently observed in BC, we further evaluated 12 families with both a history of PC and a blood relative with primary BC. The overall LOD score in these 12 families was 3.22 at a recombination fraction (theta) of .06, with marker D1S507. On the basis of an a priori hypothesis, this group was stratified by age at diagnosis of PC. In the younger age group (mean age at diagnosis <66 years), a maximum two-point LOD score of 3.65 at straight theta = .0 was observed, with D1S407. This linkage was rejected in both early- and late-onset families without a history of BC (LOD scores -7.12 and -6.03, respectively, at straight theta = .0). After exclusion of 3 of the 12 families that had better evidence of linkage to previously described PC-susceptibility loci, linkage to the 1p36 region was suggested by a two-point LOD score of 4.74 at straight theta = .0, with marker D1S407. We conclude that a significant proportion of these families with both a high risk for PC and a family member with BC show linkage to the 1p36 region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10053012      PMCID: PMC1377795          DOI: 10.1086/302287

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  Model misspecification and multipoint linkage analysis.

Authors:  N Risch; L Giuffra
Journal:  Hum Hered       Date:  1992       Impact factor: 0.444

Review 2.  Hereditary prostate cancer: epidemiologic and clinical features.

Authors:  B S Carter; G S Bova; T H Beaty; G D Steinberg; B Childs; W B Isaacs; P C Walsh
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

3.  Mendelian inheritance of familial prostate cancer.

Authors:  B S Carter; T H Beaty; G D Steinberg; B Childs; P C Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Family history and the risk of prostate cancer.

Authors:  G D Steinberg; B S Carter; T H Beaty; B Childs; P C Walsh
Journal:  Prostate       Date:  1990       Impact factor: 4.104

5.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

6.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

Authors:  G S Bova; B S Carter; M J Bussemakers; M Emi; Y Fujiwara; N Kyprianou; S C Jacobs; J C Robinson; J I Epstein; P C Walsh
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.

Authors:  D T Ransom; S R Ritland; C A Moertel; R J Dahl; J R O'Fallon; B W Scheithauer; D W Kimmel; P J Kelly; O I Olopade; M O Diaz
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

9.  Evidence for a prostate cancer susceptibility locus on the X chromosome.

Authors:  J Xu; D Meyers; D Freije; S Isaacs; K Wiley; D Nusskern; C Ewing; E Wilkens; P Bujnovszky; G S Bova; P Walsh; W Isaacs; J Schleutker; M Matikainen; T Tammela; T Visakorpi; O P Kallioniemi; R Berry; D Schaid; A French; S McDonnell; J Schroeder; M Blute; S Thibodeau; H Grönberg; M Emanuelsson; J E Damber; A Bergh; B A Jonsson; J Smith; J Bailey-Wilson; J Carpten; D Stephan; E Gillanders; I Amundson; T Kainu; D Freas-Lutz; A Baffoe-Bonnie; A Van Aucken; R Sood; F Collins; M Brownstein; J Trent
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

View more
  74 in total

1.  Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.

Authors:  J Cui; M P Staples; J L Hopper; D R English; M R McCredie; G G Giles
Journal:  Am J Hum Genet       Date:  2001-04-11       Impact factor: 11.025

2.  Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.

Authors:  K A Goddard; J S Witte; B K Suarez; W J Catalona; J M Olson
Journal:  Am J Hum Genet       Date:  2001-04-13       Impact factor: 11.025

3.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

4.  A genomic scan of families with prostate cancer identifies multiple regions of interest.

Authors:  M Gibbs; J L Stanford; G P Jarvik; M Janer; M Badzioch; M A Peters; E L Goode; S Kolb; L Chakrabarti; M Shook; R Basom; E A Ostrander; L Hood
Journal:  Am J Hum Genet       Date:  2000-05-19       Impact factor: 11.025

5.  Evidence for a prostate cancer-susceptibility locus on chromosome 20.

Authors:  R Berry; J J Schroeder; A J French; S K McDonnell; B J Peterson; J M Cunningham; S N Thibodeau; D J Schaid
Journal:  Am J Hum Genet       Date:  2000-05-16       Impact factor: 11.025

6.  Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.

Authors:  R Berry; D J Schaid; J R Smith; A J French; J J Schroeder; S K McDonnell; B J Peterson; Z Y Wang; J D Carpten; S G Roberts; D J Tester; M L Blute; J M Trent; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

7.  Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer.

Authors:  C H Bock; J M Cunningham; S K McDonnell; D J Schaid; B J Peterson; R J Pavlic; J J Schroeder; J Klein; A J French; A Marks; S N Thibodeau; E M Lange; K A Cooney
Journal:  Am J Hum Genet       Date:  2001-02-06       Impact factor: 11.025

8.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

9.  Genomewide scans of complex human diseases: true linkage is hard to find.

Authors:  J Altmüller; L J Palmer; G Fischer; H Scherb; M Wjst
Journal:  Am J Hum Genet       Date:  2001-09-14       Impact factor: 11.025

10.  A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.

Authors:  C L Hsieh; I Oakley-Girvan; R R Balise; J Halpern; R P Gallagher; A H Wu; L N Kolonel; L E O'Brien; I G Lin; D J Van Den Berg; C Z Teh; D W West; A S Whittemore
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.